Skip to main content
Premium Trial:

Request an Annual Quote

U.S. Genomics Takes License to Locked Nucleic Acid from Exiqon

NEW YORK, April 14 (GenomeWeb News) - U.S. Genomics has licensed locked nucleic acid technology from Exiqon, the companies said today.


Under the global licensing agreement, U.S. Genomics will incorporate locked nucleic acid chemistries from Copenhagen, Denmark-based Exiqon into reagent kits for its Trilogy platform for the analysis of single molecules.


U.S. Genomics, based in Woburn, Mass., plans to include LNA into reagent kits in the third quarter of this year. The first application will be to measure small RNAs, according to the company.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.